Literature DB >> 28847534

Increased BAFF and APRIL levels in the cerebrospinal fluid of patients with anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis.

Yasuhiro Shimojima1, Dai Kishida2, Yoshiki Sekijima3.   

Abstract

Hypertrophic pachymeningitis (HP) is an inflammatory disorder involving intracranial or spinal thickened dura mater. It has been recognized that anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis may lead to HP; however, the immune-mediated pathogenesis of ANCA-related HP (ANCA-HP) remains elusive. In the present study, we analyzed B-cell activation factor of the tumor necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) expression in the cerebrospinal fluid (CSF) and serum of patients with ANCA-HP, multiple sclerosis (MS), and non-inflammatory neurological disorders (NIND). BAFF and APRIL levels in the CSF were significantly higher in patients with ANCA-HP than in those with MS and NIND. In addition, a positive correlation between BAFF levels in the CSF and IgG-index was found in patients with ANCA-HP. On the other hand, no correlation was detected between CSF and serum levels of BAFF or APRIL. The results suggest that increased levels of BAFF and APRIL produced in the central nervous system may influence the development of ANCA-HP.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  A proliferation-inducing ligand; Anti-neutrophil cytoplasmic antibody; B-cell activation factor of the TNF family; Cerebrospinal fluid; Hypertrophic pachymeningitis; IgG-index

Mesh:

Substances:

Year:  2017        PMID: 28847534     DOI: 10.1016/j.cyto.2017.08.013

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  3 in total

1.  Cerebrospinal fluid biomarkers implicated in the pathogenesis of anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis.

Authors:  Junji Ikeda; Yasuhiro Shimojima; Yoko Usami; Ken-Ichi Ueno; Dai Kishida; Yoshiki Sekijima
Journal:  Clin Rheumatol       Date:  2020-02-08       Impact factor: 2.980

Review 2.  Hypertrophic pachymeningitis in polyarteritis nodosa: a case-based review.

Authors:  Shun Nomura; Yasuhiro Shimojima; Yasufumi Kondo; Dai Kishida; Yoshiki Sekijima
Journal:  Clin Rheumatol       Date:  2021-11-02       Impact factor: 2.980

3.  Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS).

Authors:  Yasuhiro Shimojima; Dai Kishida; Takanori Ichikawa; Takashi Kida; Nobuyuki Yajima; Satoshi Omura; Daiki Nakagomi; Yoshiyuki Abe; Masatoshi Kadoya; Naoho Takizawa; Atsushi Nomura; Yuji Kukida; Naoya Kondo; Yasuhiko Yamano; Takuya Yanagida; Koji Endo; Shintaro Hirata; Kiyoshi Matsui; Tohru Takeuchi; Kunihiro Ichinose; Masaru Kato; Ryo Yanai; Yusuke Matsuo; Ryo Nishioka; Ryota Okazaki; Tomoaki Takata; Takafumi Ito; Mayuko Moriyama; Ayuko Takatani; Yoshia Miyawaki; Toshiko Ito-Ihara; Takashi Kawaguchi; Yutaka Kawahito; Yoshiki Sekijima
Journal:  Arthritis Res Ther       Date:  2022-08-23       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.